Michel Vounatsos, Biogen CEO (Biogen via YouTube)
May 3, 2022 04:59 PM EDT
People

Bio­gen CEO Vounatsos, board and top ex­ecs for­mal­ly agreed to keep the breakup civ­il

John Carroll

Editor & Founder

If the pleas­antries ex­changed to­day be­tween the Bio­gen board and CEO Michel Vounatsos looked a bit in­tri­cate­ly script­ed to you, even by cor­po­rate PR stan­dards …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times